Ignite Creation Date:
2024-05-06 @ 8:26 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02736448
Status:
UNKNOWN
Last Update Posted:
2021-02-26
First Post:
2016-04-07
Brief Title:
177Lutethium - Peptide Receptor Radionuclide Therapy Lu-PRRT Plus Capecitabine Versus Lu-PRRT in FDG Positive Gastro-entero-pancreatic Neuroendocrine Tumors
Sponsor:
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Organization:
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-07
First Submit QC Date:
April 12 2016
Study First Post Date:
2016-04-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-25
Last Update Post Date:
2021-02-26
Last Update Post Date Type:
ACTUAL